Your browser doesn't support javascript.
loading
Production and Characterisation of Stabilised PV-3 Virus-like Particles Using Pichia pastoris.
Sherry, Lee; Grehan, Keith; Swanson, Jessica J; Bahar, Mohammad W; Porta, Claudine; Fry, Elizabeth E; Stuart, David I; Rowlands, David J; Stonehouse, Nicola J.
Affiliation
  • Sherry L; School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK.
  • Grehan K; School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK.
  • Swanson JJ; School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK.
  • Bahar MW; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford OX3 7BN, UK.
  • Porta C; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford OX3 7BN, UK.
  • Fry EE; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford OX3 7BN, UK.
  • Stuart DI; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford OX3 7BN, UK.
  • Rowlands DJ; Diamond Light Source, Harwell Science and Innovation Campus, Didcot OX11 0DE, UK.
  • Stonehouse NJ; School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK.
Viruses ; 14(10)2022 09 30.
Article in En | MEDLINE | ID: mdl-36298714
ABSTRACT
Following the success of global vaccination programmes using the live-attenuated oral and inactivated poliovirus vaccines (OPV and IPV), wild poliovirus (PV) is now only endemic in Afghanistan and Pakistan. However, the continued use of these vaccines poses potential risks to the eradication of PV. The production of recombinant PV virus-like particles (VLPs), which lack the viral genome offer great potential as next-generation vaccines for the post-polio world. We have previously reported production of PV VLPs using Pichia pastoris, however, these VLPs were in the non-native conformation (C Ag), which would not produce effective protection against PV. Here, we build on this work and show that it is possible to produce wt PV-3 and thermally stabilised PV-3 (referred to as PV-3 SC8) VLPs in the native conformation (D Ag) using Pichia pastoris. We show that the PV-3 SC8 VLPs provide a much-improved DC antigen ratio as compared to wt PV-3, whilst exhibiting greater thermostability than the current IPV vaccine. Finally, we determine the cryo-EM structure of the yeast-derived PV-3 SC8 VLPs and compare this to previously published PV-3 D Ag structures, highlighting the similarities between these recombinantly expressed VLPs and the infectious virus, further emphasising their potential as a next-generation vaccine candidate for PV.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Poliomyelitis / Poliovirus Vaccines / Poliovirus Limits: Humans Language: En Journal: Viruses Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Poliomyelitis / Poliovirus Vaccines / Poliovirus Limits: Humans Language: En Journal: Viruses Year: 2022 Document type: Article